Kristina Althoff

1.7k total citations
21 papers, 727 citations indexed

About

Kristina Althoff is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Kristina Althoff has authored 21 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Neurology and 6 papers in Oncology. Recurrent topics in Kristina Althoff's work include Neuroblastoma Research and Treatments (13 papers), Protein Degradation and Inhibitors (7 papers) and interferon and immune responses (4 papers). Kristina Althoff is often cited by papers focused on Neuroblastoma Research and Treatments (13 papers), Protein Degradation and Inhibitors (7 papers) and interferon and immune responses (4 papers). Kristina Althoff collaborates with scholars based in Germany, Belgium and United States. Kristina Althoff's co-authors include Johannes H. Schulte, Alexander Schramm, Anneleen Beckers, Angelika Eggert, Andrea Odersky, Frank Speleman, Lukas C. Heukamp, Theresa Thor, Jo Vandesompele and Annika Sprüssel and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Cancer Research.

In The Last Decade

Kristina Althoff

21 papers receiving 721 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristina Althoff Germany 14 547 256 197 154 85 21 727
Katia Balmas Bourloud Switzerland 15 532 1.0× 284 1.1× 175 0.9× 221 1.4× 137 1.6× 19 719
Veronica Veschi Italy 16 444 0.8× 190 0.7× 181 0.9× 266 1.7× 114 1.3× 26 701
Marli E. Ebus Netherlands 12 452 0.8× 317 1.2× 162 0.8× 243 1.6× 35 0.4× 14 681
Hauke Sieverts Germany 8 506 0.9× 205 0.8× 121 0.6× 214 1.4× 133 1.6× 13 749
Andrew E. Tee Australia 16 746 1.4× 179 0.7× 373 1.9× 133 0.9× 40 0.5× 18 909
Ganna Oliynyk Sweden 9 418 0.8× 163 0.6× 212 1.1× 130 0.8× 262 3.1× 13 768
Cécile Pierre‐Eugène France 11 267 0.5× 123 0.5× 99 0.5× 82 0.5× 60 0.7× 17 427
Roma H. Patel United States 11 470 0.9× 74 0.3× 99 0.5× 138 0.9× 39 0.5× 16 582
Carine Nyalendo Canada 14 290 0.5× 86 0.3× 310 1.6× 264 1.7× 72 0.8× 21 662

Countries citing papers authored by Kristina Althoff

Since Specialization
Citations

This map shows the geographic impact of Kristina Althoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristina Althoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristina Althoff more than expected).

Fields of papers citing papers by Kristina Althoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristina Althoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristina Althoff. The network helps show where Kristina Althoff may publish in the future.

Co-authorship network of co-authors of Kristina Althoff

This figure shows the co-authorship network connecting the top 25 collaborators of Kristina Althoff. A scholar is included among the top collaborators of Kristina Althoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristina Althoff. Kristina Althoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Ben, Rui Fang, Hendrik Schürmann, et al.. (2025). PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinoma. Cell Reports. 44(4). 115541–115541. 1 indexed citations
2.
Reinhardt, Julia, Susanna S. Ng, Julian Philipp Layer, et al.. (2021). Druggable epigenetic suppression of interferon-induced chemokine expression linked to MYCN amplification in neuroblastoma. Journal for ImmunoTherapy of Cancer. 9(5). e001335–e001335. 25 indexed citations
3.
Depta, Laura, Niklas Uhlenbrock, Jörn Weisner, et al.. (2021). Cellular model system to dissect the isoform-selectivity of Akt inhibitors. Nature Communications. 12(1). 5297–5297. 32 indexed citations
4.
Lindner, Sven, Yi Bei, Heathcliff Dorado García, et al.. (2019). Synergistic activity of BET inhibitor MK-8628 and PLK inhibitor Volasertib in preclinical models of medulloblastoma. Cancer Letters. 445. 24–33. 20 indexed citations
5.
Depta, Laura, Jörn Weisner, Niklas Uhlenbrock, et al.. (2019). Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity. Angewandte Chemie International Edition. 58(52). 18823–18829. 54 indexed citations
6.
Depta, Laura, Jörn Weisner, Niklas Uhlenbrock, et al.. (2019). Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity. Angewandte Chemie. 131(52). 18999–19005. 6 indexed citations
7.
Cheung, Phyllis F., Sven‐Thorsten Liffers, Kristina Althoff, et al.. (2018). Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting. Cancer Research. 78(17). 4997–5010. 8 indexed citations
8.
Althoff, Kristina, Theresa Thor, Andrea Odersky, et al.. (2017). RITA displays anti-tumor activity in medulloblastomas independent of TP53 status. Oncotarget. 8(17). 27882–27891. 3 indexed citations
9.
Layer, Julian Philipp, Thomas Quast, Maike Effern, et al.. (2017). Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression. OncoImmunology. 6(6). e1320626–e1320626. 84 indexed citations
10.
Althoff, Kristina, Katleen De Preter, Julie Nonnekens, et al.. (2016). Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressingMYCNinhGFAP-positive cells. Oncotarget. 7(46). 74415–74426. 16 indexed citations
11.
Althoff, Kristina, Johannes H. Schulte, & Alexander Schramm. (2016). Towards diagnostic application of non-coding RNAs in neuroblastoma. Expert Review of Molecular Diagnostics. 16(12). 1307–1313. 1 indexed citations
12.
Pajtler, Kristian W., Sandra Ackermann, Kristina Althoff, et al.. (2016). The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models. Oncotarget. 8(4). 6730–6741. 31 indexed citations
13.
Henssen, Anton G., Andrea Odersky, Annabell Szymansky, et al.. (2016). Targeting tachykinin receptors in neuroblastoma. Oncotarget. 8(1). 430–443. 23 indexed citations
14.
Eggert, Angelika, Kristina Althoff, Laura Steenpaß, et al.. (2016). Pharmaceutically inhibiting polo‐like kinase 1 exerts a broad anti‐tumour activity in retinoblastoma cell lines. Clinical and Experimental Ophthalmology. 45(3). 288–296. 8 indexed citations
15.
Beckers, Anneleen, Gert Van Peer, Daniel R. Carter, et al.. (2015). MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma. Cancer Letters. 366(1). 123–132. 33 indexed citations
16.
Althoff, Kristina, Sven Lindner, Andrea Odersky, et al.. (2014). miR‐542‐3p exerts tumor suppressive functions in neuroblastoma by downregulating S urvivin. International Journal of Cancer. 136(6). 1308–1320. 68 indexed citations
17.
Beckers, Anneleen, Gert Van Peer, Daniel R. Carter, et al.. (2014). MYCN-targeting miRNAs are predominantly downregulated during MYCN-driven neuroblastoma tumor formation. Oncotarget. 6(7). 5204–5216. 32 indexed citations
18.
Althoff, Kristina, Anneleen Beckers, Emma Bell, et al.. (2014). A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies. Oncogene. 34(26). 3357–3368. 87 indexed citations
19.
Schulte, Johannes H., Kristina Althoff, Emma Bell, et al.. (2014). Abstract 3967: BET protein inhibitor OTX015 has selective anti-tumoral activity in preclinical models of MYCN- amplified neuroblastoma. Cancer Research. 74(19_Supplement). 3967–3967. 1 indexed citations
20.
Althoff, Kristina, Anneleen Beckers, Andrea Odersky, et al.. (2013). MiR‐137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A. International Journal of Cancer. 133(5). 1064–1073. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katia Balmas Bourloud Breakdown of academic impact, for papers by Veronica Veschi Breakdown of academic impact, for papers by Marli E. Ebus Breakdown of academic impact, for papers by Hauke Sieverts Breakdown of academic impact, for papers by Andrew E. Tee Breakdown of academic impact, for papers by Ganna Oliynyk Breakdown of academic impact, for papers by Cécile Pierre‐Eugène Breakdown of academic impact, for papers by Roma H. Patel Breakdown of academic impact, for papers by Carine Nyalendo
Rankless by CCL
2026